4tlw: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
==CARDS TOXIN, FULL-LENGTH== | ==CARDS TOXIN, FULL-LENGTH== | ||
<StructureSection load='4tlw' size='340' side='right' caption='[[4tlw]], [[Resolution|resolution]] 2.55Å' scene=''> | <StructureSection load='4tlw' size='340' side='right'caption='[[4tlw]], [[Resolution|resolution]] 2.55Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[4tlw]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4TLW OCA]. For a <b>guided tour on the structure components</b> use [ | <table><tr><td colspan='2'>[[4tlw]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Mycoplasma_pneumoniae_M129 Mycoplasma pneumoniae M129]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4TLW OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4TLW FirstGlance]. <br> | ||
</td></tr><tr id=' | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.55Å</td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4tlw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4tlw OCA], [https://pdbe.org/4tlw PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4tlw RCSB], [https://www.ebi.ac.uk/pdbsum/4tlw PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4tlw ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Function == | == Function == | ||
[ | [https://www.uniprot.org/uniprot/CARDS_MYCPN CARDS_MYCPN] Acts as an ADP-ribosylating toxin, which may transfer the ADP-ribosyl group from NAD(+) to specific amino acids in target proteins. Elicits cytopathic effects in mammalian cells, such as disorganization and disruption of respiratory epithelial integrity in tracheal epithelium and vacuolization in the cytoplasm of CHO and HeLa cells.<ref>PMID:16617115</ref> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 22: | Line 22: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: | [[Category: Large Structures]] | ||
[[Category: | [[Category: Mycoplasma pneumoniae M129]] | ||
[[Category: | [[Category: Becker A]] | ||
[[Category: | [[Category: GALALELDEEN A]] | ||
[[Category: | [[Category: Hart PJ]] | ||
[[Category: | [[Category: Taylor AB]] | ||